Introduction

Follicular Th cells (Tfh cells), a subset of CD4
+ T cells, stimulate and maintain the germinal center (GC) reaction, enabling B cells to produce high-affinity antibodies. Tfh cells are defined by CXCR5, which directs them to the B cell zone via gradients of the chemokine CXCL13 (1, 2) . Tfh cells express the transcription factor BCL6, which facilitates CXCR5 expression and stimulates IL-21 production, helping B cells to undergo affinity maturation and produce antibody (3) (4) (5) . Tfh cells also can produce other cytokines, including IFN-γ, IL-17, and IL-4, which may help with selection of antibody isotypes during class switch recombination.
Follicular Tregs (Tfr cells) are a newly defined population of CXCR5 + CD4 + T cells. Like Tfh cells, Tfr cells express high levels of CXCR5, ICOS, and PD-1 (6-9). However, Tfr cells are thought to originate in the periphery from thymic-derived Treg (tTreg) precursors, in contrast to Tfh cells, which develop from naive FOXP3 -T cells (7, 9) . Importantly, Tfr and Tfh cells have opposing roles in regulating humoral immunity: whereas Tfr cells potently suppress humoral immune responses, Tfh cells stimulate them (6) (7) (8) (9) . The mechanisms by which Tfr cells suppress the GC reaction are still unclear. It is not known whether Tfr cells suppress Tfh cells, GC B cells, or both. Moreover, whether specific antigen is required for Tfr suppression is also not known. Understanding how Tfr cells inhibit humoral immunity has the potential to enable improved vaccination strategies.
Tfr and Tfh cells are present not only in lymph nodes (LNs), but also in the circulation (9) . Circulating Tfh cells from humans can provide help to B cells in vitro (10, 11) , and circulating Tfh cells from mice can stimulate B cells in vivo (9) . A subset of human blood Tfh cells has been postulated to represent memory cells (1, 10, 12) . This putative memory Tfh cell subset expresses CXCR5 comparably to LN Tfh cells, but expresses less PD-1 and ICOS. However, bona fide Tfh cell memory has not been demonstrated in vivo. It is possible that circulating Tfh cells may give rise to memory Tfh cells (9, 13, 14) . Likewise, circulating Tfr cells also may have memory potential.
Elucidating the relationships between LN Tfr and Tfh cells and circulating Tfr and Tfh cells may provide insights into their memory cell development and function (2) . Although LN Tfr and Tfh cells depend on CD28, ICOS, and B cells for development, the specific cues for blood Tfr and Tfh cell development and maintenance are not yet clear (9) . It has been suggested that blood Tfh cells do not require the GC reaction for differentiation, but whether this is true for Tfr cells is unknown (15) . Circulating Tfh cells in humans appear to differ from LN Tfh cells, as assessed by microarray analysis; however, these differences may be due to decreased activation in the blood or contaminating Tfr cells (12) .
The most straightforward explanation for Tfr and Tfh cells in the circulation is that some Tfr and Tfh cells in the GC leave the LN. If this hypothesis were true, then circulating Tfr and Tfh cells would require LN Tfr and Tfh cells for their development. In support of this hypothesis, Tfr and Tfh cells are almost completely missing from the LNs and blood of CD28-and ICOS-deficient mice (9, 16, 17) . However, PD-1-deficient mice have increased Tfh cells in the blood, but not in the LN (9) . In addition, LN Tfr and Tfh cells develop with kinetics similar to those of blood Tfh and Tfr cells (9) . Moreover, recent tracking experiments suggest that GC Tfh cells are unable to gain access to the circulation (18 (Total FOXP3   + ; H-J), are included as controls. (K) Tfh and Tfr cells in dLN and blood on d10 after PR8 influenza (PR8 Flu) infection. (L) Tfh and Tfr cells in spleen and blood on d7 after LCMV CL13 infection. Uninf., uninfected control. Data are mean ± SEM with 5 mice per group and representative of ≥3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, unpaired Student's t test. Figure  1J ). Tfh and Tfr cell numbers in the blood of mice infected with influenza or with lymphocytic choriomeningitis virus (LCMV) also expanded, and these cells expressed ICOS similar to levels in NP-
Results
Circulating Tfr cells expand after protein immunization or viral infection. To determine whether blood and LN Tfr cells have phenotypic differences, we compared the expression of CXCR5 and other cell surface markers. We analyzed CXCR5 and ICOS expression on circulating and LN cells after immunization with 4-hydroxy-3-nitrophenylacetyl hapten-conjugated OVA (NP-OVA) in CFA, which causes differentiation of Tfr and Tfh cells (9) . (21). In contrast, Tfr and Tfh cells within the blood of WT and μMT mice were equivalent, which suggests that blood and LN Tfr cells require distinct cues for development, unlike LN Tfr cells.
To determine whether DCs are necessary for the generation of circulating Tfr and Tfh cells, we used BM chimeric mice (CD11c-DTR strain) to deplete DCs. Diphtheria toxin (DT) administration resulted in depletion of most DCs from CD11c-DTR mice, which consequently led to lower percentages of activated (i.e., Ki67 Differentiation of circulating Tfr cells requires priming by DCs. LN Tfh cells depend on DCs for initial differentiation (19) and on B cells for maintenance (20) (21) (22) . LN Tfr cells also depend on B cells for their differentiation and maintenance (6) . However, B cells are not essential for development of circulating Tfh cells (15) , which led us to investigate whether B cells are required for circulating Tfr cells. We immunized WT and μMT mice (which lack B cells) and compared dLN and circulating Tfr cells. As expected, Tfr and Tfh cells in the dLN were attenuated in μMT mice (Figure 2 , A-C) administered FTY720 on day 7 after immunization, at 3 or 6 hours before analysis, and found attenuation of both Tfr and Tfh numbers within a few hours ( Figure 3C ), demonstrating that these cells exit the blood quickly.
To assess the phenotype of Tfr cells when they exit the dLN, we analyzed Tfr cells in the efferent lymph via thoracic duct cannulation (25) . We found similar percentages of Tfr cells in efferent lymph, dLN, and blood ( Blood Tfr cells recirculate through the blood quickly. We next investigated the cues responsible for exit of Tfr cells from the dLN. Since sphingosine-1-phosphate (S1P) levels control T cell exit into the efferent lymph (23), we tested whether Tfr cells use S1P signals to exit the dLN. We administered FTY720, which prevents cells from responding to S1P (24) . Blood Tfr and Tfh cells were virtually absent in mice given FTY720 ( Figure 3 , A and B). To investigate the kinetics of blood Tfr circulation, we Figure 3) . We transferred these cells into Cd28 -/-recipients, which were immunized with NP-OVA. We found substantial populations of transferred cells in all LNs tested ( Figure 4A 
ICOS
-Tregs from the blood, we could not detect them in the B cell follicles (data not shown). These data indicate that circulating Tfr cells can become GC Tfr cells after secondary exposure to antigen, although it is unclear whether this happens preferentially.
In analogous studies, we transferred blood Tfh cells into WT recipient mice that were subsequently immunized. Transferred blood Tfh cells interacted with IgG1 + class-switched B cells in the interfollicular zone and in the GCs of the dLN of recipient mice ( Figure 4E and Supplemental Figure 4) . Taken together, these data indicate that circulating Tfr and Tfh cells are capable of migrating to secondary lymphoid organs and can enter GCs to interact with B cells in the GC reaction.
Circulating Tfr and Tfh cells persist in vivo, similar to memory cells. We next investigated whether circulating Tfr cells can persist in vivo, similar to memory T cells. We conducted parabiosis experiments in which the circulatory system from an immunized mouse was surgically joined with that of an unimmunized mouse, allowing exchange of circulating cells -including circulating Tfr and Tfh cells. Following immunization with NP-OVA, actin-CFP Foxp3-GFP mice were surgically joined to WT mice ( Figure 5A ). After being joined for 19 days, chimerism was confirmed, and mice were separated. The WT nonimmunized mate was then immunized, and 7 days later (i.e., at least 32 days since original partner immunization), organs were harvested. + cells was decreased in immunized compared with unimmunized WT Foxp3-GFP parabiotic mates ( Figure 5C ). This relative reduction in Tfr cells may promote initiation of the secondary response in the circulating memory CXCR5 + Tfh cells, since the Tfr/Tfh ratio can control antibody production (9) .
Although parabiosis experiments are advantageous because circulating cells can be transferred over time without loss from harvesting procedures, it is possible that CXCR5 -
FOXP3
+ memory cells may differentiate into Tfr cells in the dLN after antigen exposure. Therefore, we used a complementary approach: we transferred blood CXCR5 + cells sorted from NP-OVA-immunized actin-CFP Foxp3-GFP mice into WT recipient mice ( Figure 5D ). After 30 days, WT recipients were immunized with NP-OVA, and dLNs were harvested 7 days later. We found a small, but substantial, population of CFP + cells in the dLN and skin ( Figure 5 , E and F). Although most CFP + CXCR5 + cells were Tfh cells, there was a small Tfr population ( Figure 5G ). The CFP + cells that persisted had high levels of CXCR5 ( Figure 5H ), which suggests that many of these cells maintained their follicular phenotype. Importantly, transferred CXCR5 -ICOS -
+ blood cells (i.e., non-Tfr Tregs) could not persist in vivo ( Figure 5I ), which suggests that memorylike properties are unique to Tfr cells. However, it is important to note that we did not test CXCR5 -ICOS + Tregs, nor Tregs from tissues, which may contain other Treg memory populations. Together, these data indicate that circulating Tfr -and Tfh -cells can recirculate throughout the body for long periods of time and regulate the GC reaction after secondary exposure to antigen. Figure 6A ). Therefore, DCs can stimulate enhanced activation of circulating Tfh cells.
We next investigated whether the increased activation of circulating Tfh cells cultured with DCs resulted in greater cytokine production. We found increases in staining for IFN-γ, as well as smaller increases in staining for IL-21, IL-17A, IL-2, and IL-4, in circulating Tfh cells cultured with DCs ( Figure 6 , B and C). We We next investigated whether effector Tfr cells also affect B cell function. The GC B cell marker GL7 was upregulated on B cells when cultured with Tfh cells, but markedly reduced when Tfr cells were present ( Figure 7G ). In contrast, conventional Tregs did not reduce GL7 expression. Importantly, whereas Tfh cells stimulated robust class switch recombination in B cells, this was potently inhibited by Tfr cells ( Figure 7H ). Conventional Tregs only modestly inhibited class switch recombination, even at higher Treg ratios (Figure 7, H and I) . Tfh cell-stimulated B7-1 expression was also attenuated by Tfr cells, but not by conventional Tregs (Figure 7J) . These data indicate that LN Tfr cells, but not conventional Figure 7B ). Moreover, Tfh Ki67 expression was strongly suppressed by Tfr cells in both B cell and DC culture conditions ( Figure 7C ), which suggests that a key mechanism of effector Tfr cell suppression is the inhibition of Tfh cell cycling.
We next examined whether Tfr cells also suppress Tfh cell cytokine production. We found that Tfr cells suppressed IFN-γ, IL-21, IL-10, and TNF-α expression by Tfh cells cultured with B cells (Figure 7D ), and expression of IFN-γ, IL-10, and TNF-α in culture supernatants (Supplemental Figure 5) . We did not detect IL-21 in the cultures when B cells were used, but detected low lev- (Figure 9A) . Similarly, circulating Tfr cells reduced GL7 in B cells, but less robustly than dLN Tfh cells ( Figure 9B ). Thus, circulating Tfr cells suppress B cells by a mechanism similar to that of dLN Tfh cells, but to a lesser extent. Additionally, Ki67 expression was observed in a lower percentage of circulating than dLN Tfr cells, regardless of culture with B cells or DCs ( Figure 9C ). Therefore, circulating Tfr cells are less potently activated by DCs than are dLN Tfr cells.
Because circulating memory-like Tfh cells were more potent than effector Tfh cells, and circulating memory-like Tfr cells were inhibiting Tfh cell activation and cytokine production as well as B cell activation and class switch recombination.
Effector Tfr cells do not require specific antigen to suppress. Next, we investigated whether dLN effector Tfr cells suppress activated/ differentiated GC-like B cells. We cultured GL7 + B cells with dLN Tfh cells and either dLN Tfr cells or conventional Tregs (all sorted as in Figure 7F ) in the presence of NP-OVA for 6 days. Tfr cells were able to suppress Ki67 in Tfh cells, but CXCR5 -
ICOS
-Tregs exhibited only modest suppression ( Figure 8A ). Furthermore, there were large percentages of IgG1 + GL7
+ class-switched B cells in dLN Tfh and GL7 + B cell cocultures, which were substantially reduced by addition of dLN Tfr cells, and attenuated to a lesser degree by conventional Tregs ( Figure 8B ). In contrast, the percentages of GL7 + B cells in these cultures were greatly suppressed by Tfr cells, but not substantially by conventional Tregs (Figure 8C ). B7-1 was modestly attenuated on GL7 + B cells by both Tfr cells and conventional Tregs, to a similar extent ( Figure 8D ). These data indicate that Tfr cells have the capacity to suppress GL7 + B cells after they have already been activated.
Next, we investigated whether specific antigen is required for the suppressive capacity of Tfr cells. We sorted Tfr cells from dLNs 
Methods
Mice. WT C57BL/6, Ciita
actin-CFP, and Cd28 -/-mice were from The Jackson Laboratory. Actin-CFP Foxp3-GFP mice were generated by crossing actin-CFP mice with Foxp3-IRES-GFP (Foxp3-GFP) mice (28) . For CD11c-DTR experiments, 1 μg DT (Sigma-Aldrich) was injected i.p. every 2 days starting at day 0 (d0) after immunization, and cells were harvested on d7. In some experiments, WT mice were injected i.p. with 25 mg/kg FTY720 (Cayman Chemical), either every 2 days starting at d2 after immunization or at 3 or 6 hours before harvesting organs. Thoracic duct cannulation was performed as described previously (25) .
Immunizations and infections. For NP-OVA or NP-HEL immunization, 100 μg NP 18 -OVA or NP-HEL (Biosearch Technologies) in a 1:1 H37RA CFA (DIFCO) emulsion was injected s.c. on the mouse flanks. For influenza studies, mice were infected i.n. with 0.5 LD 50 PR8 influenza. For LCMV studies, mice were infected i.v. with 4 × 10 6 PFU LCMV Clone 13. At d7-d10 after immunization or infection, mouse less inhibitory than effector Tfr cells in vitro, we postulated that there would be differences in the effects of the total circulating and dLN CXCR5 + populations (which contain both Tfr and Tfh cells) on B cell activation in vivo. We sorted total CXCR5 + cells from dLNs or blood of NP-OVA immunized mice and transferred these cells to Cd28 -/-recipients that were immunized with NP-OVA. We detected a greater percentage of dLN GC B cells, plasma cells, and serum NP-specific antibody 10 days after immunization of the recipients of blood CXCR5 + cells (Figure 9 , D-F). We performed similar transfer experiments with mice infected with influenza. We infected mice with influenza i.n. and transferred dLN or blood CXCR5 + cells to Cd28 -/-recipients that were then infected with influenza. After 13 days, we found enhanced IgG in the serum of recipients of blood versus dLN CXCR5 + cells ( Figure 9G ). Together, these data demonstrate that blood CXCR5 + cells are able to stimulate enhanced B cell responses compared with dLN CXCR5 + cells.
Discussion
In + cells after antigen presentation by DCs. Subsets of Tfr cells that have medium-to-low CXCR5 and low CD69 expression exit the LN via S1P gradients, destined to become circulating memory-like Tfr cells. Tfr cells with high CXCR5 and CD69 expression follow CXCL13 gradients to the B cell zone, where full differentiation of the effector program occurs. Importantly, when Tfr cells entered the lymph, they already exhibited a phenotype similar to that of circulating Tfr cells, which suggests that the memory-like Tfr cell phenotype is acquired during differentiation. This hypothesis is supported by a recent study demonstrating that GC Tfh cells can move between the GC and interfollicular regions, but do not enter the circulation (18) , and another report that circulating Tfh cells, unlike LN Tfh cells, do not require SAP (or, consequently, B cells) for differentiation (15) .
Far less is known about the signals necessary for Tfr function than those for Tfr differentiation (26) . It has been suggested that there are specialized subsets of effector Tregs that use Th cell transcription factors not normally expressed by Tregs to position themselves in specific locations to help program Th-specific suppression (26 Confocal microscopy. Confocal microscopy was performed as described previously (9) . Briefly, organs were embedded in OCT medium (Tissue-Tek). 10-μm sections were cut, fixed, and stained using the FOXP3 kit (eBioscience). Samples were imaged using an Olympus confocal microscope with a ×20 objective.
Statistics. For single comparisons, unpaired, 2-tailed Student's t test was used; for multiple comparisons, 1-way ANOVA with Tukey post-test was used. Data represent mean ± SD or SEM as indicated. A P value less than 0.05 was considered significant.
Study approval. All mice were used according to the Harvard Medical School Standing Committee on Animals and NIH guidelines. BMDCs. BMDCs were prepared by culturing BM cells from WT or Ciita -/-mice with 30 ng/ml GM-CSF (Peprotech) for 7 days. During the last 24 hours, 20 ng/ml LPS (Sigma-Aldrich) and 20 μg/ml NP-OVA were added. 1 × 10 6 cells were injected s.c. into the flank of WT mice.
Flow cytometry. Cells were stained with antibodies from Biolegend (anti-CD4, RM4-5; anti-ICOS, 15F9; anti-CD19, 6D5; anti-CD69, H1.2F3; anti-CD11c, N418; anti-MHCII, M5/114.15.2; anti-IL-17A, TC11-18H10.1; anti-IL-2, JES6-5H4; anti-IFN-γ, XMG1.2; anti-IL-4, 11B11; anti-TNF-α, MP6-XT22; anti-CD138, 281-2), eBioscience (anti-FOXP3, FJK-16S; anti-BCL6, mGI191E; anti-IL-21, FFA21), BD Biosciences (anti-GL7; anti-Ki67, B56; anti-IgG1, A85-1), and Abcam (goat anti-GFP). For CXCR5 staining, biotinylated anti-CXCR5 (2G8; BD Biosciences) was used followed by BV421-or APC-conjugated streptavidin (Biolegend). For intracellular staining, FOXP3 fix/perm kit was used (eBioscience). For intracellular cytokine staining, cells were preincubated with 1 μg/ml ionomycin (Sigma-Aldrich), 500 ng/ml PMA (SigmaAldrich), and Golgistop (BD Biosciences) for 4 hours. Parabiosis. For parabiosis, mice were anesthetized and surgically joined as described previously (25) . Parabiosis was confirmed by analyzing blood CFP chimerism. Mice were separated after 19 days and immunized s.c. on the nonjoined side 6 days later. Contributions of
